undamentalytics Newsletter
Sign in

Celanese Corp (CE) stock

Add to watchlist

Add holding +

NYSE: CE NYSE Diversified Chemicals Next results ~February 16, 2027

C Fundamentals grade

Celanese Corp is a US-listed company in the diversified chemicals industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: after-tax interest is 78% of the cash flow left for shareholders; our flat discount rate doesn't yet reflect debt this heavy.

Price vs value

Under review: after-tax interest is 78% of the cash flow left for shareholders; our flat discount rate doesn't yet reflect debt this heavy. We'll show the comparison once resolved.

Celanese Corp valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders4 buying, 0 selling7 purchases and 0 sales by directors and officers, last 12 monthsInsider trades
  • Funds241 adding, 230 cuttingOf 70 active managers that changed their stake, 41 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Celanese files

Where Celanese stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $9.71bn, down 2.2% on a year earlier, faster than -5.5% a quarter earlier. That puts it 876 of 931 for growth among all the companies we cover. Free-cash-flow margin held at 7.3%. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 1 of our 6 financial-health checks. At that price, our model says the market is pricing in about 5.9% a year of cash-flow growth for five years, faster than the 2.6% a year revenue growth it has delivered.

Our model value for Celanese is under review, so past values are not shown until it is resolved.

Source: 10-Q filed August 5, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~February 16, 2027 (estimated)

Celanese Corp's trailing-twelve-month revenue fell 2.2% year on year, with a free-cash-flow margin of 7.3%. Where it stands out: stock pay as % of revenue of 0.3% ranks 22 of 137 materials companies we cover. Where it lags: long-term debt as % of assets of 56.1% ranks 142 of 147 materials companies we cover.

Our discounted-cash-flow model values the business at ~$90 per share in the base case (~$41–$150 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 12.0% while net income grew 28.7%: a 17pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

Nothing in Celanese Corp's latest figures clears our strength thresholds.

Things to watch

  • Revenue shrinking. Revenue fell 2.2% over the last 12 months.
  • Loss-making. Operating margin is -7.1%: costs exceed revenue.
  • Volatile shares. Over the past year the shares showed annualised volatility of 51% and a beta of 0.3 against the S&P 500.
  • Below peers: long-term debt as % of assets. Long-term debt as % of assets of 56.1% ranks 142 of 147 materials companies we cover (median 22.8%).
  • Missing expectations. Earnings per share fell short of the consensus estimate in 2 of the last four quarters.
  • Estimates being cut. Analysts' consensus for next year's earnings per share has fallen 6.2% over 90 days.

Latest results: FY2026 Q2

Filed August 5, 2026
Earnings per share
$1.65 against an average estimate of $1.56: beat by 5.6%
Revenue
$2.75bn, up 8.7% on a year earlier
Share reaction
-1.7% in the first session after the results on August 4, 2026, against +1.6% for the S&P 500
Guidance given
adjusted earnings per share $1.35 to $1.75 (third quarter); adjusted earnings per share $6 (the full year)
Next report
November 2, 2026; average EPS estimate $1.16

Celanese's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-2.8%
  • 1 week-0.2%
  • 1 month+8.6%
  • This year+13.7%
  • 1 year+25.0%
  • 5 years-69.1%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$9.7B
Operating margin
-7.1%
Net margin
-12.0%
EPS (TTM, diluted)
$-10.65

Growth

Revenue growth
−2.2%
Change in growth rate
+3.3 pts
Share count change
+0.5%

Cash

Free cash flow (TTM)
$708M
FCF margin
7.3%
Stock pay % of revenue
0.3%

Earnings

Last results
November 2, 2026
Next results (est.)
February 16, 2027

News & updates

Updated November 2, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Announcement
  2. Results
  3. Leadership
  4. Announcement
  5. Results
  6. Agreement
  7. Guidance

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Celanese Corp valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: held for review: after-tax interest is 78% of the cash flow left for shareholders; our flat discount rate doesn't yet reflect debt this heavy.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value Celanese Corp as an operating company, with every model that fits that kind of business. Cost of equity 9.2%: the 10-year Treasury yield (4.9%) plus a beta of 0.94 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. — Does not apply: This model is withheld pending its input or assumption review.
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$61 ~$50–$140 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$40 ~$29–$55 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$41 ~$35–$49 Included
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Celanese Corp with Materials sector in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$55.35$66.10$91.56$78.46$109.72$118.78$156.49$97.38$151.60$68.88$42.18$47.94
Market value$8.4bn$9.6bn$12.7bn$10.6bn$13.7bn$14.1bn$17.5bn$10.6bn$16.6bn$7.5bn$4.6bn$5.3bn
+ Net debt (− = net cash)$2.0bn$2.4bn$3.1bn$3.1bn$3.5bn$2.8bn$3.5bn$13.2bn$12.0bn$11.7bn$11.4bn$10.7bn
Enterprise value$10.5bn$12.0bn$15.7bn$13.7bn$17.1bn$16.9bn$21.0bn$23.9bn$28.5bn$19.2bn$16.1bn$16.0bn
Multiples
Price / sales 1.5x1.8x2.1x1.5x2.2x2.5x2.1x1.1x1.5x0.7x0.5x0.5x
Price / earnings 27.7x10.7x15.0x8.8x16.1x7.1x9.3x5.6x8.5x———
Price / free cash flow 13.4x14.9x23.6x8.7x12.6x14.4x13.6x8.3x12.5x14.2x5.8x7.4x
EV / EBITDA 15.3x9.8x13.6x8.2x14.4x16.6x9.1x13.0x12.0xn/m—111.9x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

56 /100

Moderate moat

How hard Celanese's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 11 / 20

    Cash operating profit has been a median 8.8% of total assets over 10 years.

  • Pricing power 8 / 20

    Gross margin has been a median 24.1%, moving by 2.9 percentage points (standard deviation) across 10 years.

  • Durability 4 / 20

    Operating margin has been a median 14.4%; its worst year was -7.8%.

  • Cash conversion 15 / 20

    Free cash flow was positive in 10 of 10 years, at a median 10.6% of revenue.

  • Discipline 18 / 20

    The diluted share count fell 4.9% over five years; stock-based pay has been a median 0.7% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $6.00 +51% $10.0bn +5%
Next $6.03 +0% $9.9bn −1%

Next year's EPS estimate has moved −6.2% in 90 days, across 17 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −0.8% on 90 days ago. In the last 30 days, 2 analysts raised Celanese Corp's forecast and 2 cut it.

Consensus EPS forecast Celanese Corp, last 90 days
$5.80 $6.00 $6.20 $6.40 $6.60 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $6.05 Current fiscal year, 60 days ago: $5.97 Current fiscal year, 30 days ago: $5.98 Current fiscal year, 7 days ago: $6.00 Current fiscal year, Now: $6.00 $6.00 Next fiscal year, 90 days ago: $6.42 Next fiscal year, 60 days ago: $6.18 Next fiscal year, 30 days ago: $6.18 Next fiscal year, 7 days ago: $6.02 Next fiscal year, Now: $6.03 $6.03

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $6.05$6.42
60 days ago $5.97$6.18
30 days ago $5.98$6.18
7 days ago $6.00$6.02
Now $6.00$6.03

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $1.56 $1.65 +5.6%
Jun 2026 $2.22 $2.45 +10.2%
Mar 2026 $0.90 $0.85 −5.2%
Dec 2025 $0.91 $0.67 −26.3%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, August 4, 2026
  • adjusted earnings per share the full year about $6.00 Non-GAAP Maintained
    “While earnings are expected to moderate from the strong second quarter level, we remain focused on executing the initiatives within our control and continue to expect approximately $6.00 of adjusted earnings per share and $700 to $800 million of free cash flow for the full year.” source
  • adjusted earnings per share third quarter $1.35 to $1.75 Non-GAAP
    “Based on these dynamics, we expect third quarter adjusted earnings per share of approximately $1.35 to $1.75.” source
  • free cash flow the full year $700m to $800m Non-GAAP Maintained
    “While earnings are expected to moderate from the strong second quarter level, we remain focused on executing the initiatives within our control and continue to expect approximately $6.00 of adjusted earnings per share and $700 to $800 million of free cash flow for the full year.” source
  • effective tax rate for 2026 adjusted earnings the full year 2026 about 8% Non-GAAP
    “The effective tax rate for 2026 adjusted earnings was also 8 percent for the second quarter, and we anticipate this rate for the full year 2026 based on expected jurisdictional earnings mix for the full year and consideration of other non-recurring U.S. GAAP items.” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

Analyst recommendations

18 analysts, Nov 2026
Buy1056%
Hold844%
Sell00%

Monthly trend

  1. Nov 20269818
  2. Oct 202629617
  3. Sep 202628616

Counts of recommendations published by analysts covering Celanese Corp, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
8.3%
of tradable shares
Days to cover
3.15
at average volume
Short interest, 1 month
−18%
to October 15, 2026
Held by institutions
—
of shares
Held by insiders
0.4%
of shares
Employees
11,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +25.0%

$38.35 on October 31, 2025 to $47.94

ThenNowEffect
Revenue (last 12 months) $9.9bn $9.7bn −2.2%
P/S multiple 0.4x 0.5x +28.4%
Share count 109m 110m −0.5%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years −59.4%

$118.03 on November 3, 2023 to $47.94

ThenNowEffect
Revenue (last 12 months) $10.3bn $9.7bn −5.7%
P/S multiple 1.3x 0.5x −56.8%
Share count 109m 110m −0.4%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
CE+32%−38%+56%−55%−39%+14%
Industry peers (median)——————
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
CE67%50%50%33%50%55%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
CE−14%−49%−21%−60%−52%−38%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 79% from March 28, 2024 to November 20, 2025. Getting back needed a 375% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$35.45 – $69.15
From 52-week high
−30.7%
vs 50-day average
+4.2%
vs 200-day average
−7.0%
Volatility (1 year)
51%
Beta vs S&P 500
0.31

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
2 up, 9 down
typical move ±9.6%
After a week
3 up, 8 down
typical move ±12.1%
After a month
5 up, 6 down
typical move ±13.7%
Results releasedNext dayS&P 500 next day5 days21 days
August 4, 2026 −1.7% +1.6% +2.2% +6.3%
May 5, 2026 −9.6% +2.2% −13.5% −21.5%
February 17, 2026 −6.8% +0.7% −9.7% +1.8%
November 6, 2025 +11.8% −1.0% +8.2% +8.4%
August 11, 2025 −14.2% +0.9% −10.3% −8.0%
May 5, 2025 +6.7% −1.4% +18.7% +19.0%
February 18, 2025 −19.3% +0.5% −20.0% −15.9%
November 4, 2024 −27.1% +1.0% −37.0% −43.2%
August 1, 2024 −6.8% −3.3% −10.4% −7.5%
May 8, 2024 −0.8% +0.6% −2.6% −10.0%
February 20, 2024 −0.5% −0.5% −1.0% +9.5%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Celanese Corp in five measures

Fundamentals grade C
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Celanese Corp
$9B $9.5B $10B $10.5B $11B FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $10.7B Revenue (TTM), FY23 Q4: $10.9B Revenue (TTM), FY24 Q1: $10.7B Revenue (TTM), FY24 Q2: $10.5B Revenue (TTM), FY24 Q3: $10.5B Revenue (TTM), FY24 Q4: $10.3B Revenue (TTM), FY25 Q1: $10B Revenue (TTM), FY25 Q2: $9.9B Revenue (TTM), FY25 Q3: $9.7B Revenue (TTM), FY25 Q4: $9.5B Revenue (TTM), FY26 Q1: $9.5B Revenue (TTM), FY26 Q2: $9.7B $9.7B

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $10.7B
FY23 Q4 $10.9B
FY24 Q1 $10.7B
FY24 Q2 $10.5B
FY24 Q3 $10.5B
FY24 Q4 $10.3B
FY25 Q1 $10B
FY25 Q2 $9.9B
FY25 Q3 $9.7B
FY25 Q4 $9.5B
FY26 Q1 $9.5B
FY26 Q2 $9.7B
Revenue growth, TTM YoY Celanese Corp
-10% 0% 10% 20% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: 11.7% Revenue growth, TTM YoY, FY23 Q4: 13.0% Revenue growth, TTM YoY, FY24 Q1: 7.0% Revenue growth, TTM YoY, FY24 Q2: 2.4% Revenue growth, TTM YoY, FY24 Q3: -2.4% Revenue growth, TTM YoY, FY24 Q4: -6.0% Revenue growth, TTM YoY, FY25 Q1: -6.0% Revenue growth, TTM YoY, FY25 Q2: -5.8% Revenue growth, TTM YoY, FY25 Q3: -7.3% Revenue growth, TTM YoY, FY25 Q4: -7.1% Revenue growth, TTM YoY, FY26 Q1: -5.5% Revenue growth, TTM YoY, FY26 Q2: -2.2% -2.2%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 11.7%
FY23 Q4 13.0%
FY24 Q1 7.0%
FY24 Q2 2.4%
FY24 Q3 -2.4%
FY24 Q4 -6.0%
FY25 Q1 -6.0%
FY25 Q2 -5.8%
FY25 Q3 -7.3%
FY25 Q4 -7.1%
FY26 Q1 -5.5%
FY26 Q2 -2.2%
Operating margin (TTM) Celanese Corp
-30% -20% -10% 0% 10% 20% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: 13.8% Operating margin (TTM), FY23 Q4: 15.2% Operating margin (TTM), FY24 Q1: 15.2% Operating margin (TTM), FY24 Q2: 14.6% Operating margin (TTM), FY24 Q3: 9.0% Operating margin (TTM), FY24 Q4: -7.0% Operating margin (TTM), FY25 Q1: -7.6% Operating margin (TTM), FY25 Q2: -7.8% Operating margin (TTM), FY25 Q3: -23.7% Operating margin (TTM), FY25 Q4: -8.2% Operating margin (TTM), FY26 Q1: -7.8% Operating margin (TTM), FY26 Q2: -7.1% -7.1%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 13.8%
FY23 Q4 15.2%
FY24 Q1 15.2%
FY24 Q2 14.6%
FY24 Q3 9.0%
FY24 Q4 -7.0%
FY25 Q1 -7.6%
FY25 Q2 -7.8%
FY25 Q3 -23.7%
FY25 Q4 -8.2%
FY26 Q1 -7.8%
FY26 Q2 -7.1%
FCF margin (TTM) Celanese Corp
0% 5% 10% 15% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: 9.6% FCF margin (TTM), FY23 Q4: 12.2% FCF margin (TTM), FY24 Q1: 14.6% FCF margin (TTM), FY24 Q2: 10.7% FCF margin (TTM), FY24 Q3: 8.1% FCF margin (TTM), FY24 Q4: 5.2% FCF margin (TTM), FY25 Q1: 5.0% FCF margin (TTM), FY25 Q2: 6.4% FCF margin (TTM), FY25 Q3: 10.6% FCF margin (TTM), FY25 Q4: 8.4% FCF margin (TTM), FY26 Q1: 9.2% FCF margin (TTM), FY26 Q2: 7.3% 7.3%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 9.6%
FY23 Q4 12.2%
FY24 Q1 14.6%
FY24 Q2 10.7%
FY24 Q3 8.1%
FY24 Q4 5.2%
FY25 Q1 5.0%
FY25 Q2 6.4%
FY25 Q3 10.6%
FY25 Q4 8.4%
FY26 Q1 9.2%
FY26 Q2 7.3%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Dec 2009 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 5.1 5.9 6.8 6.4 6.5 6.8 5.7 5.4 6.1 7.2 6.3 5.7 8.5 9.7 10.9 10.3 9.5 9.7
Gross profit 1.0 1.2 1.4 1.2 1.4 1.6 1.3 1.4 1.5 2.0 1.6 1.3 2.7 2.4 2.6 2.3 2.0 2.0
EBITDA 0.6 0.8 0.7 0.5 1.8 1.1 0.7 1.2 1.2 1.7 1.2 1.0 2.3 1.8 2.4 0.1 −0.0 0.1
Operating income 0.3 0.5 0.4 0.2 1.5 0.8 0.3 0.9 0.9 1.3 0.8 0.7 1.9 1.4 1.7 −0.7 −0.8 −0.7
Net income 0.5 0.4 0.4 0.4 1.1 0.6 0.3 0.9 0.8 1.2 0.9 2.0 1.9 1.9 1.9 −1.5 −1.2 −1.2
Diluted EPS $3.17 $2.38 $2.69 $2.33 $6.91 $4.00 $2.00 $6.18 $6.09 $8.91 $6.84 $16.75 $16.86 $17.34 $17.76 −$14.11 −$10.64 −$10.65
Growth (year on year)
Revenue −25.5% +16.5% +14.3% −5.1% +1.4% +4.5% −16.6% −5.0% +13.9% +16.5% −12.0% −10.2% +51.0% +13.3% +13.0% −6.0% −7.1% −2.2%
EBITDA −25.3% +32.1% −11.4% −31.0% +275.4% −42.1% −35.0% +79.2% −5.1% +44.3% −29.3% −14.5% +128.5% −20.6% +28.9% −96.6% — —
Operating income −34.1% +73.4% −20.1% −56.5% +761.7% −49.7% −57.0% +186.5% −8.2% +55.7% −37.5% −20.4% +193.1% −29.2% +20.8% −143.2% — —
Net income +77.2% −24.3% +13.3% −12.9% +196.0% −43.3% −51.3% +196.1% −6.3% +43.2% −29.4% +133.0% −4.8% +0.2% +2.6% −179.4% — —
Diluted EPS +84.3% −24.9% +13.0% −13.4% +196.6% −42.1% −50.0% +209.0% −1.5% +46.3% −23.2% +144.9% +0.7% +2.8% +2.4% −179.4% — —
Margins
Gross margin 19.7% 19.9% 21.0% 18.4% 21.0% 23.8% 23.2% 26.1% 24.6% 27.6% 25.5% 22.9% 31.4% 24.6% 23.6% 22.8% 20.5% 20.9%
EBITDA margin 11.8% 13.3% 10.4% 7.5% 27.8% 15.4% 12.0% 22.7% 18.9% 23.4% 18.8% 17.9% 27.1% 19.0% 21.7% 0.8% −0.3% 1.5%
Operating margin 5.7% 8.5% 5.9% 2.7% 23.2% 11.1% 5.7% 17.3% 14.0% 18.6% 13.2% 11.7% 22.8% 14.2% 15.2% −7.0% −8.2% −7.1%
Net margin 9.8% 6.4% 6.3% 5.8% 16.9% 9.2% 5.4% 16.7% 13.7% 16.9% 13.5% 35.1% 22.1% 19.6% 17.8% −15.0% −12.2% −12.0%
Free-cash-flow margin 8.3% 4.2% 4.3% 5.8% 7.5% 10.4% 11.1% 12.0% 8.7% 17.1% 17.2% 17.3% 15.1% 13.2% 12.2% 5.2% 8.4% 7.3%
Cash flow
Cash from operations 0.6 0.5 0.6 0.7 0.8 1.0 0.9 0.9 0.8 1.6 1.5 1.3 1.8 1.8 1.9 1.0 1.1 1.0
Capital spending 0.2 0.2 0.3 0.3 0.3 0.3 0.2 0.2 0.3 0.3 0.4 0.4 0.5 0.5 0.6 0.4 0.3 0.3
Free cash flow 0.4 0.3 0.3 0.4 0.5 0.7 0.6 0.6 0.5 1.2 1.1 1.0 1.3 1.3 1.3 0.5 0.8 0.7
Stock-based pay — — — 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0
Free cash flow after stock pay — — — 0.4 0.5 0.7 0.6 0.6 0.5 1.2 1.0 1.0 1.2 1.2 1.3 0.5 0.8 0.7
Balance sheet
Cash 1.3 0.7 0.7 1.0 1.0 0.8 1.0 0.6 0.6 0.4 0.5 1.0 0.5 1.5 1.8 1.0 1.3 1.4
Total debt 3.5 3.2 3.0 3.1 3.1 2.7 3.0 3.0 3.7 3.5 3.9 3.7 4.0 14.8 13.8 12.6 12.7 12.1
Net debt (negative = net cash) 2.2 2.5 2.3 2.1 2.1 2.0 2.0 2.4 3.1 3.1 3.5 2.8 3.5 13.2 12.0 11.7 11.4 10.7
Diluted shares 157m 158m 159m 160m 159m 156m 152m 146m 138m 135m 125m 118m 112m 109m 109m 109m 110m 110m
Returned to shareholders
Dividends 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0
Buybacks 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.5 0.5 0.8 1.0 0.7 1.0 0.0 0.0 0.0 — —
Total returned 0.0 0.1 0.1 0.1 0.2 0.4 0.6 0.7 0.7 1.1 1.3 0.9 1.3 0.3 0.3 0.3 0.0 0.0

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

1 of 6 checks passed · June 30, 2026
What it owns · $21.4bn
Short-term assets $5.8bnLonger-term assets $15.6bn
What it owes, and who funded it · $8.2bn
Short-term liabilities $4.0bnShareholders' equity $4.2bn
  • Short-term assets cover short-term liabilities $5.8bn of assets due within a year against $4.0bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities Not assessable from the reported split. Not assessable.
  • More cash than debt $1.4bn of cash against $13.3bn of debt.
  • Debt below 40% of shareholders' equity Debt is 320% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 76% to 320% over five years.
  • A year's operating cash flow covers at least 20% of debt $984m of operating cash flow against $13.3bn of debt.
  • Operating profit covers interest at least five times over Operating income of −$692m against $723m of interest.

From Celanese Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Dividends (TTM)
$13M
Diluted share count
+0.5%
year over year
Total shareholder yield
0.3%
dividends 0.3% + buybacks 0.0% of market value
R&D spending
1.2%
of revenue
Sales & admin spending
9.6%
of revenue
Days sales outstanding
48 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in diversified chemicals
Last 12 months unless stated CE EMN HUN Median
Revenue, last 12 months $9.7bn $9.0bn $5.9bn $9.0bn
Revenue growth, last 12 months −2.2% 0.3% 0.6% 0.3%
Revenue growth, 3-year average −1.9% −1.2% −4.9% −1.9%
Revenue growth, latest quarter 8.7% 8.3% 14.1% 8.7%
Gross margin 20.9% 20.6% 13.5% 20.6%
Operating margin −7.1% 16.0% −0.5% −0.5%
Operating margin, 3-year average −0.1% 15.2% −0.9% −0.1%
Net margin −12.0% 6.9% −3.1% −3.1%
Cash from operations / revenue 10.1% 9.7% 2.7% 9.7%
Free-cash-flow margin 7.3% 5.2% −0.2% 5.2%
Free-cash-flow margin, 3-year average 8.1% 5.3% 1.2% 5.3%
Stock pay / revenue 0.3% 0.8% 0.5% 0.5%
Change in share count 0.5% −1.1% 0.4% 0.4%

Median of all 3 companies we cover in diversified chemicals. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

171 materials companies
Measure Company Peer median Rank
Revenue growth Growth -2.2% 8.3% 138 of 170
Change in growth rate Growth +3.3pp +2.4pp 75 of 168
Gross margin Profitability 20.9% 26.1% 90 of 151
Operating margin Profitability -7.1% 7.0% 110 of 140
Net margin Profitability -12.0% 3.8% 131 of 170
Free-cash-flow margin Cash generation 7.3% 5.0% 66 of 167
Stock pay as % of revenue Cash generation 0.3% 0.7% 22 of 137
Long-term debt as % of assets Balance sheet 56.1% 22.8% 142 of 147
Change in share count Balance sheet 0.5% 0.4% 88 of 161
Days sales outstanding Balance sheet 48 days 45 days 73 of 125

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Engineered Materials $5.4B 56.5% ▼ 3.7%
Acetyl Chain $4.2B 43.5% ▼ 11.1%
Geography
Region Revenue Share YoY
United States $2.6B 26.9% ▼ 6.1%
Switzerland $2.5B 25.9% ▲ 740.1%
China $1.8B 18.8% ▼ 9.7%
Germany $750M 7.9% ▼ 65.9%
Singapore $707M 7.4% ▼ 29.4%
Japan $290M 3.0% ▲ 4.3%
Mexico $243M 2.5% ▼ 29.4%
Other Foreign Countries $212M 2.2% ▼ 54.7%
India $148M 1.6% ▼ 4.5%
Brazil $127M 1.3% ▼ 9.3%
South Korea $127M 1.3% ▼ 9.3%
Canada $108M 1.1% ▼ 15.0%
BE $2M 0.0% ▼ 99.5%

From Celanese Corp's 10-K filed February 24, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$5.6B
Institutions reporting
458
Shares held vs prior quarter
▲ 12.5%
Positions opened / closed
76 / 92

Top buyers and sellers, Q2 2026: 241 institutions bought and 230 sold ; the biggest buyer was Voya Investment Management LLC (+2.1M shares) and the biggest seller Federated Hermes, Inc (−1.3M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Dodge & Cox $703M 15.3M 12.6% ▼ 0.4%
Blackrock, Inc. $615M 13.4M 11.0% ▲ 2.1%
Norges Bank $430M 9.3M 7.7% —
Vanguard Portfolio Management LLC $300M 6.5M 5.4% ▲ 4.1%
Vanguard Capital Management LLC $229M 5.0M 4.1% ▲ 0.4%
State Street Corp $185M 4.0M 3.3% ▲ 1.3%
Capital Research Global Investors $173M 3.8M 3.1% ▼ 20.1%
Fuller & Thaler Asset Management, Inc. $162M 3.5M 2.9% ▼ 5.4%
Dimensional Fund Advisors LP $160M 3.5M 2.9% ▲ 58.8%
Capital World Investors $140M 3.0M 2.5% 0.0%
Federated Hermes, Inc. $116M 2.5M 2.1% ▼ 33.3%
Turtle Creek Asset Management Inc. $105M 2.3M 1.9% ▼ 10.4%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Celanese Corp's complete shareholder register. Values are as reported by the filers ; 1 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $593,258 7 trades by 4 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $593,258 net buying
Insider Date Trade Shares Price Value
Kyrish Chuck SVP & CFO August 14, 2026 Buy 100 $45.51 $4,551
Kyrish Chuck SVP & CFO August 14, 2026 Buy 1,400 $45.53 $63,742
Kyrish Chuck SVP & CFO August 14, 2026 Buy 800 $45.51 $36,408
Murray Mark Christopher SVP - Acetyls August 11, 2026 Buy 2,153 $45.52 $98,005
Duffie Ashley B SVP & GC August 11, 2026 Buy 600 $45.60 $27,360
Richardson Scott A CEO & President December 10, 2025 Buy 3,800 $41.59 $158,042
Kyrish Chuck SVP & CFO December 9, 2025 Buy 5,000 $41.03 $205,150

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 18 trades and filings

No trades in Celanese Corp disclosed in the last 12 months; 18 earlier trades on record.

  • Kathy E. Manning(D-NC 6):Sale (full), $1,001 - $15,000, traded August 3, 2022, filed September 14, 2022
  • Kathy E. Manning(D-NC 6):Purchase, $1,001 - $15,000, traded July 20, 2022, filed August 10, 2022
  • Dwight Evans(D-PA 3):Sale (full), $1,001 - $15,000, traded March 30, 2022, filed April 25, 2022

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around February 16, 2027 estimated from the company's past filing pattern, not announced

  • November 2, 2026
  • August 4, 2026
  • May 5, 2026
  • February 17, 2026
  • November 6, 2025
  • August 11, 2025

Recent SEC filings

Data status

When each part of this page on Celanese Corp was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Celanese Corp in brief

What does Celanese Corp do?
Celanese Corp is a US-listed company in the diversified chemicals industry. Its financial year ends in December.
What is Celanese Corp's stock ticker?
Celanese Corp trades under the ticker CE on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Celanese Corp's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Celanese Corp reported revenue of $9.7B, 2.2% lower than a year earlier, according to its SEC filings.
What is Celanese Corp's free cash flow?
Celanese Corp's free-cash-flow margin is 7.3% of revenue over the trailing twelve months, ranking 66 of the 167 materials companies we cover.
Who are Celanese Corp's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Dodge & Cox, Blackrock, Inc. and Norges Bank. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Celanese Corp's market cap?
On November 2, 2026, Celanese Corp's market capitalisation was about $5.3B and net debt of $10.7B. Market figures come from third-party market data and may be delayed.
Does Celanese Corp pay a dividend?
Yes: Celanese Corp paid $13M in dividends over the trailing twelve months, a dividend yield of 0.25%.
How much debt does Celanese Corp have?
Celanese Corp's debt-to-equity ratio is 319.8%, from its latest balance sheet (75.8% five years earlier). The financial health section below sets out its other solvency checks.
Who are Celanese Corp's competitors?
In our Diversified Chemicals peer group, the companies closest to Celanese Corp are Eastman Chemical Co and Huntsman Corp. The side-by-side comparison below sets their revenue, margins and growth against Celanese Corp's.
Are insiders buying or selling Celanese Corp stock?
Over the last 12 months, Celanese Corp's directors and officers reported 7 open-market purchases and 0 sales on Form 4. The insider trading page charts every trade.
When is Celanese Corp's next earnings date?
Around February 16, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Celanese Corp announces its own schedule.